DEF 14A

Company

Anixa Biosciences Inc

Filed

September 12, 2019

Period of Report

September 12, 2019

Accession Number

0001513162-19-000205

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →